Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04366531 · ClinicalTrials.gov registry record · NA
Successful Transitions and Reintegration Tools for Veterans (START-VETS)
A NA study of Substance Use Disorder and Mental Illness, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04366531: Recruiting NA study of Substance Use Disorder and Mental Illness, sponsored by VA Office of Research and Development.
NCT04366531 is a NA study of Substance Use Disorder and Mental Illness that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 20 participants, below the 821-participant average among 18 other Substance Use Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04366531, a NA study of Substance Use Disorder and Mental Illness, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will develop prison reentry materials for Veterans leaving prison.
Primary Outcome
The Brief Symptom Inventory - 18 evaluates the domains of Somatization, Depression, and Anxiety. Each scale has 6 items, with a range of 0-24. Higher indicates a higher amount of the identified construct, i.e a worse outcome.
Conditions Studied
Interventions
- OTHER Treatment as usual
- BEHAVIORAL START-VET
Study Locations (1)
Texas
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-08-03 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT04366531 shows while recruiting
NCT04366531 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 821-participant average among 18 other Substance Use Disorder trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Substance Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Treatment as usual is the first listed.
NCT04366531 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04366531 about?
NCT04366531 is a clinical study titled "Successful Transitions and Reintegration Tools for Veterans (START-VETS)". This study will develop prison reentry materials for Veterans leaving prison.
What is the current status of trial NCT04366531?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2020-08-03. Estimated completion is 2026-12-31.
What conditions does trial NCT04366531 study?
This clinical trial studies the following conditions: Substance Use Disorder, Mental Illness, Recently Incarcerated.
What interventions are being tested in trial NCT04366531?
The interventions under investigation include: Treatment as usual (OTHER), START-VET (BEHAVIORAL).
Who is sponsoring clinical trial NCT04366531?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04366531 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04366531's enrollment target sits among peer trials
20 18th of 18 the lowest of 18 other Substance Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smoking Cessation CM for Veterans With or at Risk for Cancer
RECRUITING · NA
-
A Type I Hybrid Effectiveness-Implementation Trial of MIO
RECRUITING · NA
-
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
RECRUITING · NA
-
Personalized Approach to Healthy Use and Recovery (PATH) Trial
RECRUITING · NA
-
Defining Neurobiological Links Between Substance Use and Mental Illness
RECRUITING · NA
-
A Digital Intervention to Decrease Self-Stigma Among Pregnant and Postpartum Women With Substance Use Disorder
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI